Polycythemia
Showing 426 - 447 of 447
Hypoxia Trial in Zürich and Jungfraujoch (mountain) (altitude)
Unknown status
- Hypoxia
- altitude
-
Zürich and Jungfraujoch (mountain), SwitzerlandUniversity of Zürich and the JUngfraujoch Research Station
Jun 21, 2012
Chronic Myeloproliferative Disorders Trial in Portland (imatinib mesylate)
Terminated
- Chronic Myeloproliferative Disorders
- imatinib mesylate
-
Portland, OregonOHSU Knight Cancer Institute
Dec 1, 2011
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +7 more
- anti-thymocyte globulin
- +4 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
Dec 7, 2011
Hemodialysis Fluid Allergy Trial in Zonguldak (Dry weight adjustment)
Unknown status
- Hemodialysis Fluid Allergy
- Dry weight adjustment
-
Zonguldak, Devrek, Turkey
- +9 more
Nov 9, 2011
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in United States (aldesleukin, recombinant interferon alfa)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- aldesleukin
- recombinant interferon alfa
-
Newport Beach, California
- +4 more
May 10, 2011
Chronic Myeloproliferative Disorders, Secondary Myelofibrosis Trial (drug, other, procedure)
Completed
- Chronic Myeloproliferative Disorders
- Secondary Myelofibrosis
- cyclophosphamide
- +5 more
- (no location specified)
Mar 16, 2011
Chronic Myeloproliferative Disorders, Secondary Myelofibrosis Trial in Scottsdale, Rochester (azacitidine)
Terminated
- Chronic Myeloproliferative Disorders
- Secondary Myelofibrosis
-
Scottsdale, Arizona
- +1 more
Apr 19, 2011
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in New York (fluorouracil, leucovorin calcium, topotecan HCl)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- fluorouracil
- +2 more
-
New York, New YorkKaplan Cancer Center
Mar 25, 2011
Cancer Trial in London, Edinburgh, Glasgow (drug, other, procedure)
Unknown status
- Cancer
- ketamine hydrochloride
- +4 more
-
London, England, United Kingdom
- +2 more
May 12, 2011
The Role of Erythropoietin in Myelodysplastic Syndrome
Completed
- Myelodysplastic Syndrome
-
Salt Lake City, Utah
- +1 more
Nov 22, 2010
Biological Data With Potential Prognostic Relevance in
Unknown status
- Myelodysplastic Syndrome
-
Coppito, L'Aquila, Italy
- +13 more
Feb 7, 2011
Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in Seattle (busulfan, cyclophosphamide, cyclosporine)
Completed
- Chronic Myeloproliferative Disorders
- +3 more
- busulfan
- +4 more
-
Seattle, Washington
- +1 more
Sep 14, 2010
Chronic Myeloproliferative Disorders Trial in France, United Kingdom, United States (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- filgrastim
- +4 more
-
Anchorage, Alaska
- +8 more
Jun 15, 2010
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Seattle (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +4 more
- anti-thymocyte globulin
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
May 12, 2010
Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic/Myeloproliferative Diseases Trial in Seattle (busulfan,
Completed
- Chronic Myeloproliferative Disorders
- +2 more
- busulfan
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Mar 31, 2010
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Seattle (drug, procedure, radiation)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- cyclophosphamide
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Mar 31, 2010
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Tucson (mAb A27.15, mAb E2.3)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- monoclonal antibody A27.15
- monoclonal antibody E2.3
-
Tucson, ArizonaArizona Cancer Center
Mar 12, 2010
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in New Brunswick (tetradecanoylphorbol acetate)
Terminated
- Chronic Myeloproliferative Disorders
- +6 more
- tetradecanoylphorbol acetate
-
New Brunswick, New JerseyCancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Me
Jan 25, 2010
Hypoglycemia Trial in Ankara (Human insulin, Human Insulin)
Completed
- Hypoglycemia
- Human insulin
- Human Insulin
-
Ankara, TurkeyGulhane School of Medicine Department of Endocrinology and Metab
Nov 12, 2009
Bone Marrow Transplant Chart Review for RIC
Completed
- Myelofibrosis
- Reduced Intensity Conditioning (RIC) Allogenic Transplant
-
Houston, Texas
- +3 more
Oct 8, 2009